Profile
Full Name
ArriVent BioPharma, Inc.Ticker Symbol
AVBPExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
January 26, 2024Indexes
Not includedWebsite
http://arrivent.comEmployees
52Key Details
Price
$20.82(-1.65%)
Market cap
$708.22M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$2.56(-17.99% YoY)
PE ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
ArriVent BioPharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 20, 25 B. Riley Securities
BuyMar 10, 25 Guggenheim
BuyMar 7, 25 HC Wainwright & Co.
BuyJan 22, 25 HC Wainwright & Co.
BuyNov 15, 24 HC Wainwright & Co.
BuySep 11, 24 Citigroup
BuySep 10, 24 Oppenheimer
OutperformSep 10, 24 HC Wainwright & Co.
BuySep 10, 24 Goldman Sachs
BuyAug 16, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for ArriVent BioPharma?
- Does ArriVent BioPharma pay dividends?
- What sector is ArriVent BioPharma in?
- What industry is ArriVent BioPharma in?
- What country is ArriVent BioPharma based in?
- When did ArriVent BioPharma go public?
- Is ArriVent BioPharma in the S&P 500?
- Is ArriVent BioPharma in the NASDAQ 100?
- Is ArriVent BioPharma in the Dow Jones?
- When was ArriVent BioPharma's last earnings report?
- When does ArriVent BioPharma report earnings?
- Should I buy ArriVent BioPharma stock now?
What is the ticker symbol for ArriVent BioPharma?
The ticker symbol for ArriVent BioPharma is NASDAQ:AVBP
Does ArriVent BioPharma pay dividends?
No, ArriVent BioPharma does not pay dividends
What sector is ArriVent BioPharma in?
ArriVent BioPharma is in the Healthcare sector
What industry is ArriVent BioPharma in?
ArriVent BioPharma is in the Biotechnology industry
What country is ArriVent BioPharma based in?
ArriVent BioPharma is headquartered in United States
When did ArriVent BioPharma go public?
ArriVent BioPharma's initial public offering (IPO) was on January 26, 2024
Is ArriVent BioPharma in the S&P 500?
No, ArriVent BioPharma is not included in the S&P 500 index
Is ArriVent BioPharma in the NASDAQ 100?
No, ArriVent BioPharma is not included in the NASDAQ 100 index
Is ArriVent BioPharma in the Dow Jones?
No, ArriVent BioPharma is not included in the Dow Jones index
When was ArriVent BioPharma's last earnings report?
ArriVent BioPharma's most recent earnings report was on Mar 3, 2025
When does ArriVent BioPharma report earnings?
The next expected earnings date for ArriVent BioPharma is May 30, 2025
Should I buy ArriVent BioPharma stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions